Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

FCSC

Fibrocell Science (FCSC)

Fibrocell Science Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FCSC
DateHeureSourceTitreSymboleSociété
07/01/202016h30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FCSCFibrocell Science Inc
18/12/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FCSCFibrocell Science Inc
17/12/201923h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
13/12/201922h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FCSCFibrocell Science Inc
13/12/201922h04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FCSCFibrocell Science Inc
13/12/201915h41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FCSCFibrocell Science Inc
13/12/201915h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
22/11/201912h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FCSCFibrocell Science Inc
14/11/201922h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FCSCFibrocell Science Inc
28/10/201921h04Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FCSCFibrocell Science Inc
26/10/201900h00PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Fibrocell Science, Inc.NASDAQ:FCSCFibrocell Science Inc
11/10/201922h52Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:FCSCFibrocell Science Inc
25/09/201922h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FCSCFibrocell Science Inc
17/09/201922h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FCSCFibrocell Science Inc
13/09/201900h35PR Newswire (US)Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
12/09/201923h40GlobeNewswire Inc.Castle Creek Pharmaceutical Holdings to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
29/08/201922h53Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FCSCFibrocell Science Inc
14/08/201922h45GlobeNewswire Inc.Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
30/05/201914h00GlobeNewswire Inc.Fibrocell to Present at BIO International Convention 2019NASDAQ:FCSCFibrocell Science Inc
29/05/201914h00GlobeNewswire Inc.Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEBNASDAQ:FCSCFibrocell Science Inc
15/05/201913h30GlobeNewswire Inc.Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
09/05/201914h00GlobeNewswire Inc.Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and ...NASDAQ:FCSCFibrocell Science Inc
29/04/201922h22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FCSCFibrocell Science Inc
15/04/201912h30GlobeNewswire Inc.Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene TherapyNASDAQ:FCSCFibrocell Science Inc
03/04/201914h00GlobeNewswire Inc.Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate DirectorsNASDAQ:FCSCFibrocell Science Inc
27/03/201921h40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FCSCFibrocell Science Inc
27/03/201912h30GlobeNewswire Inc.Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-00...NASDAQ:FCSCFibrocell Science Inc
20/03/201913h00GlobeNewswire Inc.Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019NASDAQ:FCSCFibrocell Science Inc
14/02/201920h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FCSCFibrocell Science Inc
06/02/201914h00GlobeNewswire Inc.Fibrocell to Present at 21st Annual BIO CEO & Investor ConferenceNASDAQ:FCSCFibrocell Science Inc
 Showing the most relevant articles for your search:NASDAQ:FCSC

Dernières Valeurs Consultées